Table: Kobayashi Pharmaceutical - 6-MTH group results
Jul 29 (Reuters)-
Kobayashi Pharmaceutical Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Jun 30, 2021 Jun 30, 2020 Dec 31, 2021
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 67.05 66.18 156.00
(+1.3 pct) (-4.5 pct) (+3.6 pct)
Operating 10.24 10.22 26.00
(+0.2 pct) (-8.2 pct) (+0.2 pct)
Recurring 11.09 11.03 27.80
(+0.6 pct) (-5.2 pct) (+0.3 pct)
Net 7.88 8.22 19.50
(-4.1 pct) (+0.2 pct) (+1.5 pct)
EPS 100.84 yen 105.14 yen 249.48 yen
Ann Div 77.00 yen 81.00 yen
-Q2 div 37.00 yen 34.00 yen
-Q4 div 43.00 yen 44.00 yen
NOTE - Kobayashi Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4967.T
Recent news on Kobayashi Pharmaceutical
See all newsNotice Regarding Certain Media Reports
Brief: Japan's Kobayashi Pharmaceutical Considering Going Private Under Japan-UK Investment Fund Consortium, Bloomberg News Says
Brief: Oasis Management Raises Stake In Kobayashi Pharmaceutical To 14.41% From 13.37%, Filing Shows
Table: Kobayashi Pharmaceutical - 6-MTH group results
Brief: Oasis Management Company Is Making Shareholder Proposal To Kobayashi Pharmaceutical Co, Filing Shows